White Paper

Viral Disinfectant Efficacy Studies: Key Guiding Factors And Design Elements

GettyImages-1173376974 cleanroom, disinfection

Viral Disinfectant Efficacy Studies (DES) are essential in validating the effectiveness of disinfectants in regulated manufacturing environments such as pharmaceutical, biotechnology, medical device, and compounding pharmacy facilities. These studies ensure that disinfection protocols are scientifically proven to reduce or eliminate viral contaminants, thus aligning with stringent regulatory standards from agencies like the FDA, EMA, and others.

DES are typically required during key facility changes—such as new site construction, changes in cleaning procedures or disinfectant formulations, renovations, or process modifications. Non-compliance with disinfection validation requirements can result in FDA Form 483 citations, fines, or even shutdowns.

DES follow standardized testing methodologies set by organizations such as ASTM, ISO, and the EPA. Testing involves applying disinfectants to virus-inoculated surfaces under realistic manufacturing conditions and assessing effectiveness through Log Reduction Values (LRVs). A 3.0 log₁₀ reduction (99.9% inactivation) is generally the minimum acceptable standard for disinfectants on non-porous surfaces like stainless steel, glass, or plastics.

Contract Research Organizations (CROs), like Eurofins BioPharma Product Testing (EBPT), play a critical role by offering specialized labs, regulatory expertise, and unbiased third-party validation. They guide manufacturers in selecting appropriate disinfectants, designing studies, and managing virus challenges—including enveloped and non-enveloped viruses—to reflect worst-case scenarios.

Ultimately, successful DES ensure compliance, improve safety, and protect product quality. Partnering with a CRO supports effective implementation, mitigates risk, and ensures that validated cleaning protocols meet evolving industry expectations and global regulatory standards. EBPT provides expert support to streamline the DES process and ensure robust disinfection programs.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Eurofins Biopharma Product Testing